Quality Resource Guide

Local Delivery of Agents to Treat Periodontal Diseases 4th Edition

www.metdental.com

References

Socransky SS, Haffajee AD. Periodontal microbial ecology.

Periodontology 2000 2005;38(1):135-87.

Goodson JM, Holborow D, Dunn RL, Hogan P,

Dunham S. Monolithic tetracycline-containing fibers for

controlled delivery to periodontal pockets. J Periodontol

1983;54(10):575-9.

Drisko

CH.

Non-surgical

pocket

therapy:

pharmacotherapeutics. Ann Periodontol 1996;1(1):491-566.

Ciancio SG, Cobb CM, Leung M. Tissue concentration

and localization of tetracycline following site-specific

tetracycline fiber therapy. J Periodontol 1992;63(10):849-

53.

Mombelli A, Schmid B, Rutar A, Lang NP. Local antibiotic

therapy guided by microbiological diagnosis. J Clin

Periodontol 2002;29(8):743-9.

Bonito AJ, Lux L, Lohr KN. Impact of local adjuncts to

scaling and root planing in periodontal disease therapy: a

systematic review. J Periodontol 2005;76(8):1227-36.

Hanes PJ, Purvis JP. Local anti-infective therapy:

pharmacological agents. A systematic review. Ann

Periodontol 2003;8(1):79-98.

Matesanz-Perez P, Garcia-Gargallo M, Figuero E, et al.

A systematic review on the effects

of local antimicrobials

as adjuncts to subgingival debridement, compared with

subgingival debridement alone, in the treatment of chronic

periodontitis. J Clin Periodontol

2013;40(3):227- 41.

Ciancio S. The meaning of means. Periodontal Insights

1999;6(1).

10. Jeffcoat

MK,

Bray

KS,

Ciancio

SG,

al. Adjunctive

use of a subgingival controlled- release chlorhexidine

chip reduces probing depth and improves attachment

level compared with scaling and root planing alone. J

Periodontol 1998;69(9):989-97.

11. Paquette DW. Pocket depth reduction as an outcome

measure of inflammation and soft tissue changes in

periodontitis trials. J Int Acad Periodontol 2005;7(4

Suppl):147-56.

12. Paquette DW, Hanlon A, Lessem J, Williams RC. Clinical

relevance of adjunctive minocycline microspheres in

patients with chronic periodontitis: secondary analysis of a

phase 3 trial. J Periodontol 2004;75(4):531-6.

13. Paquette D, Oringer R, Lessem J, et al. Locally delivered

minocycline microspheres for the treatment of periodontitis

in smokers. J Clin Periodontol 2003;30(9):787-94.

14. Soskolne WA, Chajek T, Flashner M, et al. An in vivo

study of the chlorhexidine release profile of the PerioChip

in the gingival crevicular fluid, plasma and urine. J Clin

Periodontol 1998;25(12):1017-21.

15. Stabholz A, Sela MN, Friedman M, Golomb G, Soskolne

A. Clinical and microbiological effects of sustained release

chlorhexidine in periodontal pockets. J Clin Periodontol

1986;13(8):783-8.

16. Matesanz, Paula, et al. “A randomized clinical trial on

the clinical and microbiological efficacy of a xanthan

gel with chlorhexidine for subgingival use.” Clinical oral

investigations 17.1 (2013): 55-66.

17. Wennstrom JL, Newman HN, MacNeill SR, et al. Utilisation

of locally delivered doxycycline in non-surgical treatment of

chronic periodontitis. A comparative multi-centre trial of 2

treatment approaches. J Clin Periodontol 2001;28(8):753-

61.

18. Stoller NH, Johnson LR, Trapnell S, Harrold CQ, Garrett S.

The pharmacokinetic profile of a biodegradable controlled-

release delivery system containing doxycycline compared

to systemically delivered doxycycline in gingival crevicular

fluid, saliva, and serum. J Periodontol 1998;69(10):1085-

91.

19. Walker CB, Godowski KC, Borden L, et al. The effects

of sustained release doxycycline on the anaerobic flora

and antibiotic-resistant patterns in subgingival plaque and

saliva. J Periodontol 2000;71(5):768-74.

20. Novak MJ, Dawson DR, 3rd, Magnusson I, et al. Combining

host modulation and topical antimicrobial therapy in the

management of moderate to severe periodontitis: a

randomized multicenter trial. J Periodontol 2008;79(1):33-

41.

21. Gamal, Ahmed Y., Radi M. Kumper, and Abd El Reheem

R. Al Gendy. “Doxycycline-Loaded β-Tricalcium Phosphate

Release Following EDTA Root Surface Etching Improved

the Clinical Outcomes in Chronic Periodontitis: An In Vivo

Study.” Journal of periodontology 84.7 (2013): 924-933.

22. Madi M, Pavlic V, Samy W, Alagl A. The anti-inflammatory

effect of locally delivered nano-doxycycline gel in therapy of

chronic periodontitis. Acta Odontol Scand 2018;76(1):71-76

23. Williams RC, Paquette DW, Offenbacher S, et al.

Treatment of periodontitis by local administration of

minocycline microspheres: a controlled trial. J Periodontol

2001;72(11):1535-44.

24. Goodson

JM,

Gunsolley

JC,

Grossi

SG,

al.

Minocycline HCl microspheres reduce red- complex

bacteria in periodontal disease therapy. J Periodontol

2007;78(8):1568-79.

25. Salvi GE, Mombelli A, Mayfield L, et al. Local antimicrobial

therapy after initial periodontal treatment. J Clin Periodontol

2002;29(6):540-50.

26. Pandit, Nymphea, et al. “Comparative evaluation of locally

delivered minocycline and metronidazole in the treatment of

periodontitis.”Contemporary clinical dentistry 4.1 (2013): 48.

27. Jhinger, Navjot, Daljit Kapoor, and Rachna Jain.

“Comparison of Periochip (chlorhexidine gluconate 2.5

mg) and Arestin (Minocycline hydrochloride 1 mg) in the

management of chronic periodontitis.” Indian journal of

dentistry6.1 (2015): 20.

28. Renvert S, Samuelsson E, Lindahl C, Persson GR.

Mechanical non-surgical treatment of peri- implantitis:

a double-blind randomized longitudinal clinical study. I:

clinical results. J Clin Periodontol 2009;36(7):604-9.

29. Mombelli A, Feloutzis A, Bragger U, Lang NP. Treatment of

peri-implantitis

local

delivery of tetracycline. Clinical,

microbiological and radiological results. Clin Oral Implants

Res 2001;12(4):287-94.

30. Salvi GE, Persson GR, Heitz-Mayfield LJ, Frei M, Lang NP.

Adjunctive local antibiotic therapy in the treatment of peri-

implantitis II: clinical and radiographic outcomes. Clin Oral

Implants Res 2007;18(3):281-5.

31. Bassetti M, Schar D, Wicki B, et al. Anti-infective therapy

of peri-implantitis with adjunctive local drug delivery

or photodynamic therapy: 12-month outcomes of a

randomized controlled clinical trial. Clin Oral Implants Res

2013.

31. Schär,

Dorothee, et al. “Anti‐infective therapy of peri‐

implantitis with adjunctive local drug delivery or

photodynamic therapy: six‐month outcomes of a

prospective randomized clinical trial.” Clinical oral implants

research 24.1 (2013): 104-110.

32. Buchter A, Meyer U, Kruse-Losler B, Joos U, Kleinheinz J.

Sustained release of doxycycline for the treatment of peri-

implantitis: randomised controlled trial. Br J Oral Maxillofac

Surg 2004;42(5):439-44.

33. Machtei EE, Frankenthal S, Levi G, et al. Treatment of

peri-implantitis using multiple applications of chlorhexidine

chips: a double-blind, randomized multi- centre clinical trial.

J Clin Periodontol 2012;39(12):1198-205.

34. De Siena F, Francetti L, Corbella S, Taschieri S, Del Fabbro

M. Topical application of 1% chlorhexidine gel versus 0.2%

mouthwash in the treatment of peri-implant mucositis. An

observational study. Int J Dent Hyg 2013;11(1):41-7.

35. Esposito M, Grusovin MG, Worthington HV. Treatment

of peri-implantitis: what interventions are effective? A

Cochrane systematic review. Eur J Oral Implantol 2012;5

Suppl:S21-41.

36. Heo SJ, Kim H-J, Joo J-Y, Lee J, Kim S-J et al. Simplified

nonsurgical treatment of peri-implantitis using chlorhexidine

and minocycline hydrochloride. J Periodontal Implant Sci

2018;48(5):326-333.

37. Cha JK, Lee JS, Kim CS. Surgical therapy of peri-

implantitis with local minocycline: A 6-month randomized

controlled clinical trial. J Dent Res 2019;98(3):288-295.

38. Haffajee AD, Socransky SS, Gunsolley JC. Systemic anti-

infective periodontal therapy. A systematic review. Ann

Periodontol 2003;8(1):115-81.

39. American Academy of Periodontology Statement on Local

Delivery of Sustained or Controlled Release Antimicrobials

as Adjunctive Therapy in the Treatment of Periodontitis*.

Journal of Periodontology 2006;77(8):1458-58.

40. Killoy WJ. Chemical treatment of periodontitis: local delivery

of antimicrobials. Int Dent J 1998;48(3 Suppl 1):305-15.

41. Killoy WJ, Polson AM. Controlled local delivery of

antimicrobials in the treatment of periodontitis. Dent Clin

North Am 1998;42(2):263-83.

42. Hill M, Moore RL. Locally Acting Oral Chemotherapeutic

Agents. In: Rose LF MB, Genco RJ, Cohen W, editor.

Peridontics Medicine, Surgery and Implants: Elsevier

Mosby; 2004. p. 276 - 87.

3. Pradeep AR, Rao NS, Bajaj P, Kumari M. Efficacy of

subgingivally delivered simvastatin in the treatment of

patients with type 2 diabetes and chronic periodontitis:

a randomized double- masked controlled clinical trial. J

Periodontol 2013;84(1):24-31.

44. Pradeep AR, Rao NS, Bajaj P, Kumari M. Efficacy of

subgingivally delivered simvastatin in the treatment of

patients with type 2 diabetes and chronic periodontitis:

a randomized double- masked controlled clinical trial. J

Periodontol 2013;84(1):24-31.

45. Pradeep

AR,

Kumari

Rao

NS,

Naik

SB. 1%

alendronate gel as local

drug

delivery

in the treatment of

Class II furcation defects: a randomized controlled clinical

trial. J Periodontol 2013;84(3):307-15.

46. Zupančič, Špela, et al. “Local delivery of resveratrol using

polycaprolactone nanofibers for treatment of periodontal

disease.” Journal of Drug Delivery Science and Technology

30 (2015): 408-416.

47.

Fisher PD, Clemens J, Zach Hilt J, Puleo DA. Multifunctional

poly(β-amino ester) hydrogel microparticles in periodontal

in situ forming drug delivery systems. Biomed Mater

2016;11(2):025002.

48. Leber A, Budai-Szucs M, Urban E, Valvi P, Kovacs A et al.

Formulation and investigation of lipid based delivery system

containing antimicrobials for the treatment of periodontal

disease. Curr Drug Deliv 2018;15(6):887-897.

49. Deepak A, Goyal AK, Rath G. Development and

characterization of novel medicated nanofiber for the

treatment

periodontitis.

AAPS

PharmSciTech

2018;19(8):3687-3697.

50. Sundararaj, Sharath C., et al. “Design of a multiple drug

delivery system directed at periodontitis.” Biomaterials

34.34 (2013): 8835-8842.